Doctor insights on:
Iressa (gefitinib): See: http://www. Drugs. Com/sfx/iressa-side-effects. HtmlGet a more detailed answer ›
Iressa (gefitinib): Iressa (gefitinib) is beneficial for " treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies " See: http://dailymed. Nlm. Nih. Gov/dailymed/drugInfo. Cfm? Setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41 ...Read more
Mum diagnosed with stage 4 lung cancer. Mass in upper right airway caused major blockage. Iressa (gefitinib) treatment opens up airway. Any chances of recovery?
Targeted therapy: Newer targeted therapy agents can be quite beneficial for some patients with lung cancer. This is especially true in female never smokers who may have selected mutations that can be easily targeted with these drugs. However, unfortunately stage IV lung cancer is not curable. ...Read more
Fewer than with: Erlotinib, the tyrosine kinase inhibitor that replaced it. The scary risk was, 1% incidence of pneumonitis mostly in asians, mild diarrhea (more harsh with erlotinib), skin acne-like reactions, eye lid and nail bed problems. ...Read more
While gefitinib was: Developed first, it is hard to find in america (iressa (gefitinib)). Erlotinib (tarceva) has more side effects, but a trial showed a survival advantage. Probably more related to the characteristics of the study participants than the drug. These are small molecule, tyrosine kinase inhibitors in the erb family of receptors. Canada and europe has iressa (gefitinib). Erlotinib is in us. ...Read more